IntrinsicIntrinsic
← All summaries

Agriculture & Natural Solutions Acquisition Corp

ANSC
Financials & Chart →

Business Summary

Agriculture & Natural Solutions Acquisition Corporation (the "Company") is a blank check company incorporated in the Cayman Islands, formed to effect a business combination with one or more businesses . The Company's primary objective is to identify, acquire, and build a platform that decarbonizes the traditional agriculture sector and enhances natural capital at scale . This focus is driven by the belief that these areas represent a favorable and highly fragmented market opportunity . The Company's Sponsor, Agriculture & Natural Solutions Acquisition Sponsor LLC, is an affiliate of Riverstone Investment Group LLC and Impact Ag Partners LLC .

The Company's core business model is that of a Special Purpose Acquisition Company (SPAC), which involves raising capital through a public offering and then using those proceeds to acquire an existing operating business . The Company generates non-operating income from interest earned on funds held in a Trust Account . Its primary customer segments are not applicable as it is a blank check company seeking an acquisition. The Company's strategy is to leverage the Sponsor Entities' platforms, which have extensive experience in identifying and executing acquisitions across various sectors, including agriculture, renewable, infrastructure, upstream, and industrial services .

The Company does not have product or service lines as it is a blank check company with no operations . Its activities have been limited to organizational activities, preparing for its Public Offering, and subsequently searching for a target business .

For the fiscal year ended December 31, 2025, the Company reported a net income of $10,468,766 . This was primarily driven by $15,967,259 in interest income on the Trust Account, offset by general and administrative expenses of $5,498,493 . As of December 31, 2025, the Company had a cash balance of $1 and a working capital deficit of $17,114,663 . The cash held in the Trust Account amounted to $365,968,284 . The total liabilities were $29,404,206 , including $12,075,000 in deferred underwriting fees payable and $2,816,890 in outstanding promissory notes. The basic and diluted net income per share for Class A ordinary shares subject to possible redemption was $0.24 , based on 34,288,191 weighted average shares outstanding.

Comparing the fiscal year ended December 31, 2025, to December 31, 2024, net income increased from $8,363,892 to $10,468,766 . Interest on the Trust Account decreased from $18,605,323 in 2024 to $15,967,259 in 2025. General and administrative expenses decreased significantly from $10,241,431 in 2024 to $5,498,493 in 2025, partly due to a waiver of legal fees totaling $2,076,234 recognized in the first quarter of fiscal year 2025 related to a terminated merger transaction. Cash used in operating activities was $1,316,889 in 2025, compared to $1 provided by operating activities in 2024. The number of Class A ordinary shares subject to possible redemption decreased from 34,500,000 in 2024 to 32,922,237 in 2025 due to redemptions.

During the reported period, a significant operational development was the termination of a Business Combination Agreement on April 10, 2025, due to increasingly volatile equity market conditions . In connection with this termination, the Company and Sponsor paid an aggregate of $3,465,798 (or $5,510,620 AUD) to the Sellers . Subsequently, on November 10, 2025, shareholders approved an extension of the date by which the Company must consummate an initial business combination from November 13, 2025, to November 13, 2026 . In connection with this extension, shareholders holding 1,577,763 public shares redeemed their shares for approximately $17.4 million (or approximately $11.01 per public share) from the Trust Account. The Company also issued an Extension Promissory Note to Warrant Holdings Sponsor for up to $7,901,336.88 , with an outstanding balance of $1,316,889 as of December 31, 2025, to be deposited into the Trust Account monthly.

Business Outlook

The Company's primary outlook is centered on completing an initial business combination by the Extended Termination Date of November 13, 2026 . The Company intends to capitalize on the Sponsor Entities' platforms to identify, acquire, and build a company focused on decarbonizing the traditional agriculture sector and enhancing natural capital at scale . This strategy is based on the belief that the agriculture sector is historically underinvested and requires substantial capital to contribute to economy-wide decarbonization .

Key growth areas identified for potential target businesses include natural capital marketplaces, sequestration technologies, and ecosystem measurement and monitoring platforms, all aimed at incentivizing improved land management and accelerating sectoral decarbonization . The Company expects to develop its pipeline of opportunities through its management team's extensive experience, deep relationships, and network of corporate executives, board members, venture capital and private equity firms, family offices, investment bankers, lawyers, and investors . The Company's acquisition and value creation strategy involves identifying fundamentally sound companies that can benefit from the management team's transactional, financial, managerial, and investment experience, particularly those at an inflection point requiring additional expertise or capital for growth .

The Company's operational outlook is focused on managing its limited cash resources outside the Trust Account to cover ongoing expenses while diligently searching for a suitable business combination. The Company has a working capital deficit of $17,114,663 as of December 31, 2025, and its ability to continue as a going concern is dependent on consummating an initial business combination . General and administrative expenses are expected to continue, though the one-time waiver of legal fees in 2025 will not recur . The Company's liquidity needs are currently satisfied by net proceeds from the Public Offering and Private Placement Warrants held outside the Trust Account, and it may need additional financing to complete a business combination or cover redemptions .

Planned capital allocation includes the potential conversion of up to $1,500,000 in Working Capital Loans and the Extension Promissory Note of up to $7,901,336.88 into warrants of the post-business combination entity at $1.00 per warrant , at the option of the lender. The Company will bear the expenses incurred in connection with the filing of any registration statements for the Founder Shares, Private Placement Warrants, and warrants from working capital loans . A deferred underwriting commission of approximately $12,075,000 will be payable upon the completion of an initial business combination . The Company also has an administrative services agreement to reimburse an affiliate of its Sponsor $10,000 per month for office space, utilities, and administrative support until a business combination is completed or the Company liquidates .

Management explicitly flagged several structural headwinds and execution risks. The Company faces intense competition from other entities, including other blank check companies, private equity groups, and operating businesses, for acquisition opportunities . Its ability to acquire larger targets is limited by available financial resources, and the obligation to pay cash for redemptions may further reduce resources and make the Company less attractive to potential targets . The outstanding Warrants and their potential future dilution may also be viewed unfavorably by target businesses . The requirement to complete a business combination by the Extended Termination Date of November 13, 2026 , may give target businesses leverage in negotiations and limit due diligence time .

Geographic, regulatory, and macro factors identified as constraints include global market volatility and disruption from geopolitical instability, such as the Russia-Ukraine conflict and Middle East conflicts, which could impact commodity prices, credit and capital markets, and supply chains . Changes in U.S. trade policies, including tariffs and trade barriers, could also disrupt supply chains and trigger retaliatory efforts, negatively affecting the global economy and the Company's search for a business combination . Regulatory review and approval requirements, such as by CFIUS for foreign investments in U.S. companies, could delay or prohibit a proposed business combination . The Company's potential status as a passive foreign investment company (PFIC) could result in adverse U.S. federal income tax consequences for U.S. investors . New SEC rules (SPAC Final Rules) effective July 1, 2024, may also adversely affect the Company's ability to engage advisors, negotiate, and complete an initial business combination, increasing costs and time .

Risk Factors

The Company faces material risks including its status as a blank check company with no operating history or revenues, making its ability to achieve its business objective uncertain . The mandatory liquidation date of November 13, 2026 , creates leverage for potential target businesses and limits the time for due diligence, potentially forcing the Company into unfavorable terms or an inability to complete a business combination, leading to liquidation where public shareholders may receive less than $10.00 per share and warrants expire worthless . The independent registered public accounting firm's report expresses substantial doubt about the Company's ability to continue as a going concern due to liquidity conditions and the impending liquidation deadline . The Company's public shareholders have limited influence over the business combination decision, as the board may complete a transaction without shareholder approval, and initial shareholders have agreed to vote their shares in favor of any proposed combination . Intense competition for attractive targets, coupled with the Company's limited financial resources and redemption obligations, may hinder its ability to secure a desirable business combination . Regulatory reviews, such as by CFIUS, or new SEC rules (SPAC Final Rules) effective July 1, 2024, could delay or prohibit a business combination and increase associated costs and time . Geopolitical instability and changes in trade policies could also materially adversely affect the Company's search for a target . Furthermore, the Company is likely treated as a passive foreign investment company (PFIC), which could result in adverse U.S. federal income tax consequences for U.S. investors .

Management Priorities

Management's message to shareholders emphasizes the Company's commitment to identifying and acquiring a business that decarbonizes the traditional agriculture sector and enhances natural capital at scale, leveraging the extensive experience and networks of its Sponsor Entities, Riverstone and Impact Ag . They highlight the agriculture sector as historically underinvested and ripe for substantial investment in decarbonization, including natural capital marketplaces, sequestration technologies, and ecosystem measurement and monitoring platforms . A key strategic priority is to identify and acquire a fundamentally sound company that can benefit from the management team's transactional, financial, managerial, and investment experience, particularly those at an inflection point . Management also stressed the importance of their broad relationship network and deal-sourcing capabilities to access differentiated opportunities . The Company has extended its deadline to complete an initial business combination to November 13, 2026 , and has secured an Extension Promissory Note from Warrant Holdings Sponsor for up to $7,901,336.88 to support this extension. Despite the termination of a prior business combination agreement due to volatile equity market conditions, management remains focused on completing a suitable transaction.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Introduction
  2. [2] Item 1, Business — Our Company
  3. [3] Item 1, Business — Our Company
  4. [4] Item 7, MD&A — Overview
  5. [5] Item 1, Business — Introduction
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 1, Business — Our Company
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Results of Operations
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Results of Operations
  13. [13] Item 7, MD&A — Liquidity and Capital Resources
  14. [14] Item 7, MD&A — Liquidity and Capital Resources
  15. [15] Item 7, MD&A — Liquidity and Capital Resources
  16. [16] Item 7, MD&A — Balance Sheets
  17. [17] Item 7, MD&A — Balance Sheets
  18. [18] Item 7, MD&A — Balance Sheets
  19. [19] Item 7, MD&A — Statements of Operations
  20. [20] Item 7, MD&A — Statements of Operations
  21. [21] Item 7, MD&A — Results of Operations
  22. [22] Item 7, MD&A — Results of Operations
  23. [23] Item 7, MD&A — Statements of Operations
  24. [24] Item 7, MD&A — Statements of Operations
  25. [25] Item 7, MD&A — Statements of Operations
  26. [26] Item 7, MD&A — Statements of Operations
  27. [27] Item 7, MD&A — Statements of Operations
  28. [28] Item 7, MD&A — Statements of Cash Flows
  29. [29] Item 7, MD&A — Statements of Cash Flows
  30. [30] Item 7, MD&A — Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity
  31. [31] Item 7, MD&A — Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity
  32. [32] Item 1, Business — Termination of Business Combination Agreement
  33. [33] Item 1, Business — Termination of Business Combination Agreement
  34. [34] Item 1, Business — Termination of Business Combination Agreement
  35. [35] Item 1, Business — Extension
  36. [36] Item 1, Business — Extension
  37. [37] Item 1, Business — Extension
  38. [38] Item 1, Business — Extension
  39. [39] Item 1, Business — Extension
  40. [40] Item 1, Business — Extension
  41. [41] Item 1, Business — Extension
  42. [42] Item 1, Business — Our Company
  43. [43] Item 1, Business — Business Strategy
  44. [44] Item 1, Business — Business Strategy
  45. [45] Item 1, Business — Business Strategy
  46. [46] Item 1, Business — Acquisition Criteria
  47. [47] Item 7, MD&A — Liquidity and Capital Resources
  48. [48] Item 7, MD&A — Liquidity and Capital Resources
  49. [49] Item 7, MD&A — Results of Operations
  50. [50] Item 7, MD&A — Liquidity and Capital Resources
  51. [51] Item 7, MD&A — Liquidity and Capital Resources
  52. [52] Item 1, Business — Extension
  53. [53] Item 1, Business — Extension
  54. [54] Item 7, MD&A — Contractual Obligations
  55. [55] Item 7, MD&A — Contractual Obligations
  56. [56] Item 7, MD&A — Contractual Obligations
  57. [57] Item 7, MD&A — Contractual Obligations
  58. [58] Item 7, MD&A — Contractual Obligations
  59. [59] Item 1, Business — Competition
  60. [60] Item 1, Business — Competition
  61. [61] Item 1, Business — Competition
  62. [62] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  63. [63] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  64. [64] Item 1A, Risk Factors — General Risk Factors
  65. [65] Item 1A, Risk Factors — General Risk Factors
  66. [66] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  67. [67] Item 1A, Risk Factors — Risks Relating to our Securities
  68. [68] Item 1A, Risk Factors — General Risk Factors
  69. [69] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  70. [70] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  71. [71] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  72. [72] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  73. [73] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  74. [74] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  75. [75] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  76. [76] Item 1A, Risk Factors — Risks Relating to a Special Purpose Acquisition Company and our Securities
  77. [77] Item 1A, Risk Factors — General Risk Factors
  78. [78] Item 1A, Risk Factors — Risks Relating to our Securities
  79. [79] Item 1, Business — Our Company
  80. [80] Item 1, Business — Business Strategy
  81. [81] Item 1, Business — Acquisition Criteria
  82. [82] Item 1, Business — Business Strategy
  83. [83] Item 1, Business — Extension
  84. [84] Item 1, Business — Extension

Analysis on 5/19/2026